A Phase 2, Open-label, Multicenter Study to Evaluate Efficacy and Safety of Zanidatamab for the Treatment of Participants With Previously Treated HER2-expressing Solid Tumors (DiscovHER PAN-206)
NCT06695845 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Jazz Pharmaceuticals. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Jazz Pharmaceuticals.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Jazz Pharmaceuticals currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Jazz Pharmaceuticals conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Jazz Pharmaceuticals currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.